Case Study

How a Best-Practice Strategy For Sourcing Ancillary Materials Reduced Risk, Spending and Workload In A Global Diabetes Trial

Vials and syringe on blue table top elevated.jpg

It’s impossible to run a global clinical trial of an investigational diabetes drug without ancillary materials. And as one leading multi-national pharmaceutical company recently learned, managing ancillaries can be a challenge every bit as complex as the trial itself.

The wide variety of equipment, instruments and consumables that are collectively known as ancillaries are clinical trial necessities. A trial cannot begin unless investigator sites have supplies of both the investigational drug and the ancillary components.

While all trials require ancillaries, diabetes trials typically require a high level of these products in order to administer the investigational medicinal product (IMP). Examples include lancets, test strips and glucose meters, refrigerators for storing supplies, laptops for site administrators and even electronics such as iPhones and wearable devices that go home with study patients.

VIEW THE CASE STUDY!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: